DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo

NWIPB OpenIR

	DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo
	Li, Meng-yuan ; Lv, Yong-cong ; Tong, Lin-jiang ; Peng, Ting ; Qu, Rong ; Zhang, Tao ; Sun, Yi-ming ; Chen, Yi ; Wei, Li-xin ; Geng, Mei-yu ; Duan, Wen-hu ; Xie, Hua ; Ding, Jian
	2016-03-01
发表期刊	ACTA PHARMACOLOGICA SINICA
摘要	Aim: Targeting the VEGF/VEGF receptor (VEGFR) pathway has proved to be an effective antiangiogenic approach for cancer treatment. Here, we identified 6-((2-((3-acetamidophenyl)amino)pyrimidin-4-yl)oxy)-N-phenyl-1-naphthamide (designated herein as DW10075) as a novel and highly selective inhibitor of VEGFRs.
文献类型	期刊论文
条目标识符	http://210.75.249.4/handle/363003/22525
专题	中国科学院西北高原生物研究所
推荐引用方式 GB/T 7714	Li, Meng-yuan,Lv, Yong-cong,Tong, Lin-jiang,et al. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo[J]. ACTA PHARMACOLOGICA SINICA,2016.
APA	Li, Meng-yuan.,Lv, Yong-cong.,Tong, Lin-jiang.,Peng, Ting.,Qu, Rong.,...&Ding, Jian.(2016).DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.ACTA PHARMACOLOGICA SINICA.
MLA	Li, Meng-yuan,et al."DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo".ACTA PHARMACOLOGICA SINICA (2016).